Does fracture risk vary between diabetes drugs?

Results of a large-scale study provide reassurance on the safety of SGLT-2 inhibitors, say researchers

Doctors’ concerns over the potential of increased fracture risk in patients on sodium-glucose cotransporter 2 (SGLT-2) inhibitors should be allayed with the publication of a new study, say researchers.